Infringement in Switzerland through globally accessible website

Reading time: 3 minutes

Case No. O2019_007 | Decision of 19 November 2021 | ‘Gene sequencing’

DISCLOSURE NOTICE: Hepp Wenger Ryffel is involved in this matter on behalf of the Defendant, Latvia MGI Tech SIA.
Illumina logo

Illumina Cambridge had sued Latvia MGI Tech for infringement of two patents, i.e. EP 1 530 578 B1 (cf. EPO Register and Swissreg) and EP 1 828 412 B2 (cf. EPO Register and Swissreg); ¶ 27.

In brief, the judgment holds that both patents are valid (EP 578: ¶ 33 et seqq; EP 412: ¶ 53 et seqq.) and infringed (EP 578: ¶ 84 et seqq; EP 412: ¶ 91 et seqq.).

MGI logo

Further, the globally accessible website (and a brochure «presumably» (‘mutmasslich’) downloaded therefrom) is considered as sufficient evidence of infringement in Switzerland (offer of «[…] installation validation services, including all the reagents required for delivering such services»); ¶ 25-26.

The judgment can still be appealed to the Supreme Court.

Reported by Martin WILMING


Case No. O2019_007 | Decision of 19 November 2021 | ‘Gene sequencing’

Illumina Cambridge Limited
Latvia MGI Tech SIA

Panel of Judges:

    • Dr. Mark SCHWEIZER
    • Dr. Tobias BREMI
    • Dr. Michael KAUFMANN


    • Dr. Tobias BREMI

Court Clerk:

    • Dr. Lukas ABEGG

Representative(s) of Plaintiff:

    • Dr. Andri HESS (Homburger)
    • Julian SCHWALLER (Homburger)
    • Andrea HEINIGER (Homburger)
    • Dr. Claudia BIBUS (Blum), assisting in patent matters

Representative(s) of Defendant:

    • Dr. Thierry CALAME (Lenz & Staehelin)
    • Lara DORIGO (Lenz & Staehelin)
    • Dr. Martin WILMING (Hepp Wenger Ryffel), assisting in patent matters



EP 1 530 578 B1:

EP 1 828 412 B2:


Enter your name and email address below to get notified of new posts by email.